Fernando Lara

Title: Innovations by Fernando Lara in Pharmaceutical Chemistry

Introduction

Fernando Lara is a notable inventor based in Cuernavaca, Mexico. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of simvastatin, a widely used cholesterol-lowering medication. His innovative methods have enhanced the efficiency and purity of simvastatin production.

Latest Patents

Fernando Lara holds a patent for a method of alkylating the alpha carbon of the 2-methylbutyrate secondary chain of lovastatin. This method allows for the production of simvastatin in high yield and pharmaceutical purity. The process involves forming an amide of lovastatin and protecting the free hydroxyl groups with hexamethyldisilazane (HMDS). The protected lovastatin amide undergoes methylation to form a protected simvastatin amide, which can be hydrolyzed to produce simvastatin acid. The lactonization of the ammonium salt leads to the formation of simvastatin, which can then be recrystallized to achieve a high degree of purity.

Career Highlights

Fernando Lara is associated with Fermic S.A. de C.V., where he applies his expertise in pharmaceutical chemistry. His innovative approach to simvastatin synthesis has positioned him as a key figure in the industry. His work not only contributes to the field of pharmaceuticals but also enhances the overall efficiency of drug production.

Collaborations

Fernando has collaborated with notable colleagues such as Edvige Galeazzi and Gustavo A. Garcia. These collaborations have further enriched his research and development efforts in pharmaceutical innovations.

Conclusion

Fernando Lara's contributions to the field of pharmaceutical chemistry, particularly through his patented methods for simvastatin production, highlight his role as an influential inventor. His work continues to impact the pharmaceutical industry positively.